药品名称CEPHALEXIN
申请号062703产品号001
活性成分CEPHALEXIN市场状态处方药
剂型或给药途径FOR SUSPENSION;ORAL规格EQ 125MG BASE/5ML
治疗等效代码AB参比药物
批准日期1987/02/13申请机构TEVA PHARMACEUTICALS USA INC
化学类型审评分类
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
062703035AP2002/08/01Control Supplement
062703034AP2002/06/18Control Supplement
062703033AP2001/08/14Control Supplement
062703032AP2002/02/20Control Supplement
062703031AP2000/07/07Facility Addition
062703030AP2000/01/18Control Supplement
062703029AP1998/07/21Chemistry
062703028AP1997/08/19Chemistry
062703027AP1996/10/04Chemistry
062703026AP1996/05/10Chemistry
062703025AP1995/11/27Chemistry
062703024AP1995/02/16Chemistry
062703023AP1995/07/17Chemistry
062703022AP1994/09/06Chemistry
062703021AP1993/10/13Labeling
062703020AP1988/10/27Chemistry
062703019AP1988/09/14Chemistry
062703018AP1988/09/30Chemistry
062703017AP1988/08/04Chemistry
062703016AP1988/08/25Chemistry
062703015AP1988/05/31Chemistry
062703000AP1987/02/13Approval